Answers are grounded in this paper and cite their sources.
Objective To evaluate survival in fetuses with prenatally diagnosed Turner syndrome (TS) according to karyotype and phenotypic severity, and to estimate minimal survival (MS) proportions across cytogenetic subgroups. Methods Retrospective multicentre cohort study including fetuses with prenatal TS diagnosed between 2000 and 2024. Karyotypes were classified as 45,X; mosaic; or structural X‐chromosome anomalies. Phenotypic severity was defined by major structural abnormalities on prenatal imaging. Survival analyses and Cox proportional hazard models were applied. MS was calculated as the proportion of Live births (LB) relative to elective terminations (ET) and Spontaneous intrauterine deaths (SID) within each karyotype group. Results Among 726 pregnancies, 451 (62.1%) were ET, 275 (37.9%) continued; of these, 98 (35.6%) resulted in LB and 177 (64.4%) in SID. Severe phenotypes were present in 92.4% of terminations, 81.0% of SIDs and 33.0% of LB. Mosaic and structural karyotypes showed a lower risk of intrauterine death than 45,X (HR 0.28 and 0.32), while severe phenotype strongly predicted mortality (HR 4.82). Most SIDs occurred before 30 weeks' gestation (median 21 weeks). MS was 9.6% for 45,X, 50.0% for mosaic and 36.8% for structural variants. Conclusion Survival in prenatally diagnosed TS is higher than historically reported. Phenotypic severity is the principal determinant of outcome.
No takes yet. Share an insight, caveat, or question.
Bedei et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: